Search results
Results From The WOW.Com Content Network
FDA list of recalled eye drops. These 27 eye drop products have been recalled by the FDA as of Monday: CVS Health. Lubricant eye drops, 15 milliliters (single pack). Lubricant eye drops, 15 ...
Leader Lubricant Eye Drops 15 ml (twin pack), NDC numbers 70000-0090-2 (carton) and 70000-0090-1 (bottle)... You Might Also Like. 67 Best Gifts for Women That'll Make Her Smile.
Dorzolamide/timolol, sold under the brand name Cosopt among others, is a medication used to treat high pressure inside the eye including glaucoma. [3] [5] [6] It is a combination of dorzolamide hydrochloride and timolol maleate. [3] It may be used when a beta blocker, like timolol, is not sufficient alone. [7] It is used as an eye drop. [3]
The best eye drops for dry eyes in 2023 work to soothe various dry eye symptoms. Here, find expert-approved picks from Refresh, Systane, Opti-Free, and more.
Dorzolamide, sold under the brand name Trusopt among others, is a medication used to treat high pressure inside the eye, including in cases of glaucoma. [3] It is used as an eye drop. [3] Effects begin within three hours and last for at least eight hours. [3] It is also available as the combination dorzolamide/timolol. [3] [4]
Timolol is a beta blocker medication used either by mouth or as eye drops. [3][5] As eye drops it is used to treat increased pressure inside the eye such as in ocular hypertension and glaucoma. [3] By mouth it is used for high blood pressure, chest pain due to insufficient blood flow to the heart, to prevent further complications after a heart ...
Latanoprost, sold under the brand name Xalatan among others, is a medication used to treat increased pressure inside the eye (intraocular pressure). [5] This includes ocular hypertension and open-angle glaucoma. [5] Latanaprost is applied as eye drops to the eyes. [5] Onset of effects is usually within four hours, and they last for up to a day. [5]
Netarsudil, sold under the brand name Rhopressa among others, is a medication for the treatment of glaucoma. [1] [2] [3] In the United States, in December 2017, the Food and Drug Administration (FDA) approved a 0.02% ophthalmic solution for the lowering of elevated intraocular pressure in people with open-angle glaucoma or ocular hypertension.